Kroger fights Albertsons suit over failed $24.6 billion merger
Kroger Co. is fighting back against a lawsuit brought by Albertsons Cos. over its failed $24.6 billion takeover of the rival ...
Opinion
Why the FDA is right about Zyn
The day before announcing Zyn’s marketing authorization, FDA Center for Tobacco Products announced another proposed rule that could have a massive impact on public health: a product standard that ...
Genelux Announces Alignment with FDA on Key Elements of the Approval Pathway for Olvi-Vec in Platinum Resistant/Refractory Disease
U.S. Food and Drug Administration states that data from the ongoing OnPrime/GOG-3076 Phase 3 registrational trial could potentially support ...
Scholar Rock Application for Spinal Muscular Atrophy Treatment Gets FDA Approval
Apitegromab is an investigational treatment aimed at improving motor function for people living with spinal muscular atrophy. Scholar Rock said it has also submitted and received validation for its ...
Zacks Investment Research on MSN13h
FDA Accepts Sanofi's Filing for Multiple Sclerosis Drug Tolebrutinib
Sanofi SNY announced that the FDA has accepted its regulatory filing seeking approval for its investigational BTK inhibitor ...
JD Supra1d
Wrap-Up of Federal and State Chemical Regulatory Developments, March 2025
TSCA/FIFRA/TRI - EPA Reopens Comment Period For Proposed Rule Clarifying Supplier Notification Requirements For TRI-Listed PFAS: On ...
Pharmaceutical Technology on MSN4d
European agencies catch up with speedier regulatory pathways for CGTs in the US
Although the regulatory landscape for advanced therapy medicinal products (ATMPs) is rapidly evolving, varying regulatory ...